Bcr (7C6) Antibody sc-103 from Santa Cruz Biotechnology, Inc.

Product Specs
ItemBcr (7C6) Antibody
CompanySanta Cruz Biotechnology, Inc.
Price $316.00Supplier Page View Company Product Page
Catalog Numbersc-103
NCBI Gene AliasesE430008G22Rik, CHDSKM, ALL, CML, BCR-ABL, c-Abl, D22S11, JTK7, PHL, D22S662, BCR1, mKIAA3017, bcr/abl, c-ABL, p150, Abl, v-abl, ABL, 5133400C09Rik, c-ABL1
Antibody TypePrimary Antibodies
ApplicationsWB, IP, IF, IHC(P)
Reactivitymouse, rat, human
Quantity200 µg/ml
Clone7C6
FormatPurified
ClonalityMonoclonal
Hostmouse
Conjugate/TagUnconjugated
NCBI Full Gene NameBCR activator of RhoGEF and GTPase, c-abl oncogene 1, non-receptor tyrosine kinase, ABL proto-oncogene 1, non-receptor tyrosine kinase
TargetBcr
IsotypeIgG2a

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) The Evaluation of Rac1 Signaling as a Potential Therapeutic Target of Alzheimer's DiseaseInternational journal of molecular sciencesJuly 25, 2023Wang H, Yamahashi Y, Riedl M, Amano M, Kaibuchi K.1:400, Santa Cruz Biotechnology, Dallas, TX, USA), mouse monoclonal anti-BCR(7C6) (RRID: AB_626741, #sc-103, 1:400, Santa Cruz Biotechnology, Dallas, TX, USA), mouse monoclonal anti-ABR(24) (RRID: AB_2221350,#sc-135821,

(2) Cysteine and Folate Metabolism Are Targetable Vulnerabilities of Metastatic Colorectal CancerCancersJanuary 23, 2021Tarragó-Celada J, Foguet C, Tarrado-Castellarnau M, Marin S, Hernández-Alias X, Perarnau J, Morrish F, Hockenbery D, Gomis RR, Ruppin E, et al.

(3) Transmembrane-4 L-six family member-1 (TM4SF1) promotes non-small cell lung cancer proliferation, invasion and chemo-resistance through regulating the DDR1/Akt/ERK-mTOR axisRespiratory researchMay 29, 2019Ye L, Pu C, Tang J, Wang Y, Wang C, Qiu Z, Xiang T, Zhang Y, Peng W.(RPN2132, GE HealthcareLife Sciences, UK). Primary antibodies to the following targets were used: TM4SF1 (sc-103,267) and p-ERK (sc-7383), both Santa Cruz Biotechnology, CA, USA, cleaved caspase-3 (#9661), cleaved

(4) Erythropoietin Intensifies the Proapoptotic Activity of LFM-A13 in Cells and in a Mouse Model of Colorectal CancerInternational journal of molecular sciencesApril 23, 2018Tankiewicz-Kwedlo A, Hermanowicz JM, Pawlak K, Czarnomysy R, Bielawski K, Prokop I, Pawlak D.a thickness of 4 mm and processed as described previously [49]. The antibody used (βcR (7C6); Cat# sc-103, RRID:AB_626741) was obtained from Santa Cruz Biotechnology. 4.10. Statistical Analysis The obtained

(5) Thrombin and activated coagulation factor X stimulate the release of cytokines and fibronectin from nasal polyp fibroblasts via protease-activated receptorsAmerican journal of rhinology & allergyJanuary 1, 2017Shimizu S, Tojima I, Takezawa K, Matsumoto K, Kouzaki H, Shimizu T.

(6) Monocyte-derived dendritic cells from chronic myeloid leukaemia have abnormal maturation and cytoskeletal function that is associated with defective localisation and signalling by normal ABL1 proteinEuropean journal of haematologyAugust 1, 2014Brown S, Hutchinson CV, Aspinall-O''Dea M, Whetton AD, Johnson SM, Rees-Unwin K, Burthem J.

(7) Changes in cell adhesivity and cytoskeleton-related proteins during imatinib-induced apoptosis of leukemic JURL-MK1 cellsJournal of cellular biochemistryDecember 15, 2010Kuželová K, Pluskalová M, Grebeňová D, Pavlásková K, Halada P, Hrkal Z.

(8) Senescence evasion by MCF-7 human breast tumor-initiating cellsBreast cancer research : BCRJanuary 1, 2010Karimi-Busheri F, Rasouli-Nia A, Mackey JR, Weinfeld M.Chk1 (polyclonal, sc-7898), Chk2 (polyclonal, sc-9064), p21 (monoclonal, sc-6246), pRb (monoclonal, sc-103), phospho-Chk1 (polyclonal, sc-17922R), Cdc25A (polyclonal, sc-7157), MDM2 (monoclonal, sc-5304), p53

(9) The interaction of the Bcr-Abl tyrosine kinase with the Src kinase Hck is mediated by multiple binding domainsLeukemiaFebruary 1, 2003Stanglmaier M, Warmuth M, Kleinlein I, Reis S, Hallek M.

(10) Pim-1 expression is sufficient to induce cytokine independence in murine hematopoietic cells, but is dispensable for BCR-ABL-mediated transformationExperimental hematologyJuly 1, 2002Nosaka T, Kitamura T.

(11) A model of human p210(bcr/ABL)-mediated chronic myelogenous leukemia by transduction of primary normal human CD34(+) cells with a BCR/ABL-containing retroviral vectorBloodApril 15, 2001Zhao RC, Jiang Y, Verfaillie CM.

(12) Distinct effect of retroviral-mediated IFN-alpha gene transfer on human erythroleukemic and CD34+ cell growth and differentiationJournal of hematotherapy & stem cell researchOctober 1, 1999Quan S, Feldman E, Yang L, Wagener FA, Farley TJ, Abraham NG, Ahmed T.

(13) Requirement of two specific tyrosine residues for the catalytic activity of Bcr serine/threonine kinaseOncogeneJanuary 8, 1998Wu Y, Liu J, Arlinghaus RB.

(14) The Src family kinase Hck interacts with Bcr-Abl by a kinase-independent mechanism and phosphorylates the Grb2-binding site of BcrThe Journal of biological chemistryDecember 26, 1997Warmuth M, Bergmann M, Priess A, Häuslmann K, Emmerich B, Hallek M.

(15) Bcr phosphorylated on tyrosine 177 binds Grb2OncogeneMay 15, 1997Ma G, Lu D, Wu Y, Liu J, Arlinghaus RB.

(16) Inhibition of Bcr serine kinase by tyrosine phosphorylationMolecular and cellular biologyMarch 1, 1996Liu J, Wu Y, Ma GZ, Lu D, Haataja L, Heisterkamp N, Groffen J, Arlinghaus RB.

Be the First to Write a Review!

Bcr (7C6) Antibody

Bcr (7C6) Antibody from Santa Cruz Biotechnology, Inc.

Description

Santa Cruz Biotechnology, Inc.

Citations (16)

Reviews

Bcr (7C6) Antibody from Santa Cruz Biotechnology, Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map